Nutritional modulation of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly worldwide. It affects 30–50 million individuals and clinical hallmarks of AMD are observed in at least one third of persons over the age of 75 in industrialized countries (Gehrs et al., 2006). Costs associated with AMD are in excess of $340 billion US (American-Health-Assistance-Foundation, 2012). The majority of AMD patients in the United States are not eligible for clinical treatments (Biarnes et al., 2011; Klein et al., 2011). Preventive interventions through dietary modulation are attractive strategies because many studies suggest a benefit of micro and macronutrients with respect to AMD, as well as other age-related debilities, and with few, if any, adverse effects (Chiu, 2011). Preservation of vision would enhance quality of life for millions of elderly people, and alleviate the personal and public health financial burden of AMD (Frick et al., 2007; Wood et al., 2011). Observational studies indicate that maintaining adequate levels of omega-3 fatty acids (i.e. with 2 servings/wk of fish) or a low glycemic index diet may be particularly beneficial for early AMD and that higher levels of carotenoids may be protective, most probably, against neovascular AMD. Intervention trials are needed to better understand the full effect of these nutrients and/or combinations of nutrients on retinal health. Analyses that describe effects of a nutrient on onset and/or progress of AMD are valuable because they indicate the value of a nutrient to arrest AMD at the early stages. This comprehensive summary provides essential information about the value of nutrients with regard to diminishing risk for onset or progress of AMD and can serve as a guide until data from ongoing intervention trials are available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Glycemic index of foods: a physiological basis for carbohydrate exchange
Jenkins, D. J., Wolever, T. M., Taylor, R. H., Barker, H., Fielden, H., Baldwin, J. M., Bowling, A. C., Newman, H. C., Jenkins, A. L., & Goff, D. V. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.3.362 · Cited by 3,857 · cited 1×
“The glycemic index is a measure of the ability of 50 g of a certain food to raise blood glucose levels, relative to the ability of 50 g of a standard food to raise blood glucose levels (Jenkins et al., 1981).”
BackgroundComplement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 9×
“The CFH gene is located on the 1q31–32 chromosome, and its protein negatively regulates the alternative pathway of complement activation.”
BackgroundInfluentialComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 9×
“As might be expected given roles for complement in inflammatory pathways, inflammation is thought to play an important role in AMD pathology, and dysfunction of complement proteins may lead to an uncontrollable inflammatory response that contributes to retinal damage (Haines et al., 2005).”
BackgroundInfluentialPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 3×
“Compared to sham injection, in which a syringe (without a needle) was pressed against the eye wall, Macugen was shown to reduce visual acuity loss and attenuate the progression of CNV lesion and vessel leakage after 54 weeks of treatment (Gragoudas et al., 2004).”
BackgroundMethodHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · cited 1×
“…to better blood glucose control in diabetics, and some data also indicates that such a diet can reduce risk for cardiovascular and kidney diseases (Chiasson et al., 2002, 2003; Chiu and Taylor, 2011; Ferland et al., 2009; Jenkins et al., 2008; Liu et al., 1999; McKeown et al., 2009; Riegersperger…”
BackgroundAge-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · cited 2×
“…on complement component 2 and rs4151667 and rs641153 on complement factor B are associated with protective effects with regard to neovascular AMD risk in a metaanalysis of four cohorts, confirming the importance of the complement pathway in AMD pathology (Gold et al., 2006; Hageman et al., 2011).”
BackgroundDietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993 · cited 16×
“In the EDCC, increasing intake of total carotenoids was associated with decreased risk for neovascular AMD (OR = 0.57; 95% CI: 0.35, 0.92; p = 0.02 for trend) (Seddon et al., 1994) (Fig.”
BackgroundInfluentialA Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration
Yang, Z., Camp, N. J., Sun, H., Tong, Z., Gibbs, D., Cameron, D. J., Chen, H., Zhao, Y., Pearson, E., Li, X., et al. (2006) · Science · doi:10.1126/science.1133811 · Cited by 796
Sohal, R. S., Ku, H.-H., Agarwal, S., Forster, M. J., & Lal, H. (1994) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(94)90104-x · Cited by 788
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study
Liu, S., Stampfer, M. J., Hu, F. B., Giovannucci, E., Rimm, E., Manson, J. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.412 · Cited by 774 · cited 1×
“…in diabetics, and some data also indicates that such a diet can reduce risk for cardiovascular and kidney diseases (Chiasson et al., 2002, 2003; Chiu and Taylor, 2011; Ferland et al., 2009; Jenkins et al., 2008; Liu et al., 1999; McKeown et al., 2009; Riegersperger and Sunder-Plassmann, 2007).”
BackgroundMaiani, G., Periago Castón, M. J., Catasta, G., Toti, E., Cambrodón, I. G., Bysted, A., Granado‐Lorencio, F., Olmedilla‐Alonso, B., Knuthsen, P., Valoti, M., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800053 · Cited by 773 · cited 2×
“Lycopene is most commonly found in the American diet in tomato-based products, as reviewed by Maiani et al. (2009).”
Background(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1484 · Cited by 739 · cited 3×
“This depigmentation is often focal, round with sharp margins, and choroidal vessels may be visible underneath (Davis et al., 2005b).”
BackgroundEffect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial
Jenkins, D. J. A., Kendall, C. W. C., McKeown-Eyssen, G., Josse, R. G., Silverberg, J., Booth, G. L., Vidgen, E., Josse, A. R., Nguyen, T. H., Corrigan, S., et al. (2008) · JAMA · doi:10.1001/jama.2008.808 · Cited by 718
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582 · cited 3×
“Mass spectrometric analysis indicates that drusen contain a variety of lipids, proteins, including ubiquitin and advanced glycation end products, as well as inflammatory mediators (Ding et al., 2009) (also see review by Shang in this issue).”
BackgroundComplement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533 · cited 1×
“A recent report indicates that wild type CFH is required to remove lipid oxidation products (Weismann et al., 2011).”
BackgroundKanda, A., Chen, W., Othman, M., Branham, K. E. H., Brooks, M., Khanna, R., He, S., Lyons, R., Abecasis, G. R., & Swaroop, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703933104 · Cited by 441
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408 · cited 20×
“However, this study did find that compared to those consuming the lowest amounts of vegetable fat, those consuming the highest amounts of vegetable fat had an increased risk for neovascular AMD (OR = 2.84; 95% CI: 1.45, 5.57; p = 0.006 for trend) (Seddon et al., 2001) (Fig.”
BackgroundResultInfluentialKlein, R., Klein, B. E. K., Knudtson, M. D., Wong, T. Y., Cotch, M. F., Liu, K., Burke, G., Saad, M. F., & Jacobs, D. R. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.12.013 · Cited by 399 · cited 2×
“…80 than Caucasians (Cruickshanks et al., 1997; Frank et al., 2000; Hageman et al., 2011; Klein et al., 2003; Vanderbeek et al., 2011), there is a higher rate of nonexudative AMD among 60-year-old Asians (HR = 1.28; 95% CI: 1.20, 1.36) than Caucasians (Klein et al., 2006; Vanderbeek et al., 2011).”
BackgroundInfluentialMitochondrial alterations of retinal pigment epithelium in age-related macular degeneration
Feher, J., Kovacs, I., Artico, M., Cavallotti, C., Papale, A., & Balacco Gabrieli, C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.012 · Cited by 388 · cited 2×
“…(also see review by Jarrett and Boulton (2012)) Dysfunction of the mitochondria has been demonstrated in several neurodegenerative diseases, and mitochondrial damage has been observed in AMD patients as well (Feher et al., 2006; Hartig et al., 2011; Lakatos et al., 2010; Quintanilla et al., 2012).”
BackgroundSeddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1728 · Cited by 384 · cited 6×
“The beneficial effects of fish intake were not observed in those with higher intake or linoleic acid, nor were they observed before adjusting for linoleic acid intake (Seddon et al., 2003) (Fig.”
BackgroundResultInfluentialFACTORS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
GOLDBERG, J., FLOWERDEW, G., SMITH, E., BRODY, J. A., & TSO, M. O. M. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115023 · Cited by 384 · cited 4×
“Analyses of NHANES data collected from 1971–1972 indicated that after multivariate adjustment there was no association between vitamin C intake and prevalence of any stage of AMD (Goldberg et al., 1988) (Fig.”
BackgroundMethodInfluentialDietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration
Tan, J. S. L., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.083 · Cited by 381
Prospective study of dietary fat and the risk of age-related macular degeneration
Cho, E., Hung, S., Willett, W. C., Spiegelman, D., Rimm, E. B., Seddon, J. M., Colditz, G. A., & Hankinson, S. E. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.209 · Cited by 350
Oral Zinc in Macular Degeneration
Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C., & Miller, E. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130202026 · Cited by 349 · cited 2×
“In a study of 90 subjects, Newsome and coworkers found that 100 mg zinc twice a day for 2 years reduced vision loss (one-tailed p = 0.001) (Newsome et al., 1988).”
BackgroundInfluentialDietary intake of antioxidants and risk of age-related macular degeneration
van Leeuwen, R. (2005) · JAMA · doi:10.1001/jama.294.24.3101 · Cited by 345
Dietary fat and age-related maculopathy
Mares-Perlman, J. A. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060069034 · Cited by 298 · cited 14×
“The EDCC found no effect of fish intake on risk for neovascular AMD, nor did a retrospective study of 1968 participants of the Beaver Dam Eye Study (‘‘Beav Dam’’ in the figures) (Mares-Perlman et al., 1995b; Seddon et al., 2001) (Fig.”
BackgroundResultInfluentialMarse-Perlman, J. A., Fisher, A. I., Klein, R., Palta, M., Block, G., Millen, A. E., & Wright, J. D. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.5.424 · Cited by 286
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.5.671 · Cited by 283 · cited 12×
“Case–control analysis of the AREDS population also showed that there was no association between vitamin E intake and risk for geographic atrophy or neovascular AMD (SanGiovanni et al., 2007b) (Fig.”
BackgroundResultInfluentialCho, E. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.6.883 · Cited by 266 · cited 17×
“Similarly, the NHS + HPFUS found no association between early or neovascular AMD and vitamin A (Cho et al., 2004) (Figs.”
BackgroundResultInfluentialVandenLangenberg, G. M., Mares-Perlman, J. A., Klein, R., Klein, B. E. K., Brady, W. E., & Palta, M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009625 · Cited by 234 · cited 14×
“…of the Beaver Dam Eye Study indicated that there was a decrease in risk for pigment abnormalities 5 years after baseline for those with past zinc intake (food and supplements) in the highest quintile (OR = 0.38; 95% CI: 0.20, 1.00; p = 0.03 for trend) (VandenLangenberg et al., 1998) (Fig.”
BackgroundMethodInfluentialUchiki, T., Weikel, K. A., Jiao, W., Shang, F., Caceres, A., Pawlak, D., Handa, J. T., Brownlee, M., Nagaraj, R., & Taylor, A. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00752.x · Cited by 200 · cited 4×
“Importantly, using controlled laboratory studies, the data have been corroborated and pathophysiologic mechanisms to explain the relationships between glycemic index and AMD have been proposed (Uchiki et al., 2012; Weikel et al., 2012) (See review by Shang in this issue).”
MethodResultInfluentialSelf-citationZareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190
SanGiovanni, J. P., Agrón, E., Meleth, A. D., Reed, G. F., Sperduto, R. D., Clemons, T. E., & Chew, E. Y. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27594 · Cited by 186 · cited 1×
“Those consuming the highest amounts of DHA (OR = 0.66; 95% CI: 0.47, 0.92), EPA (OR = 0.71; 95% CI: 0.51, 0.98) and DHA + EPA (OR = 0.68; 95% CI: 0.49, 0.94) were at a reduced risk for progression to neovascular AMD compared to those consuming the lowest amounts (Sangiovanni et al., 2009) (Fig.”
BackgroundInfluentialDietary fatty acids and the 5-year incidence of age-related maculopathy
Chua, B. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.7.981 · Cited by 172
Vitamin E supplementation and macular degeneration: randomised controlled trial
Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A., & McNeil, J. J. (2002) · BMJ · doi:10.1136/bmj.325.7354.11 · Cited by 165 · cited 1×
“…cataract and maculopathy (VECAT), a clinical trial of 1193 elderly participants indicated that supplementation with 500 IU vitamin E for 4 years also had no effect on incidence of early AMD (RR = 1.05; 95% CI: 0.69, 1.61) or late AMD (RR = 1.36; 95% CI: 0.67, 2.77) (Taylor et al., 2002) (Fig.”
BackgroundInfluentialNeovascular age-related macular degeneration and its relationship to antioxidant intake
Snellen, E. L. M., Verbeek, A. L. M., Van Den Hoogen, G. W. P., Cruysberg, J. R. M., & Hoyng, C. B. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800404.x · Cited by 137
Cruickshanks, K. J. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150244015 · Cited by 131
Flood, V., Smith, W., Wang, J. J., Manzi, F., Webb, K., & Mitchell, P. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01263-0 · Cited by 109
Heuberger, R. A. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.12.1833 · Cited by 105 · cited 1×
“Cross-sectional analysis of data from the third NHANES survey also revealed that total dietary fat intake and specific types of fatty foods were not statistically related to risk for AMD (Heuberger et al., 2001).”
BackgroundApolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
Baird, P. N., Richardson, A. J., Robman, L. D., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2006) · Human Mutation · doi:10.1002/humu.20288 · Cited by 105 · cited 2×
“…receptor 4 and vascular endothelial growth factor to AMD risk, but the associations between these gene variants and AMD risk were not as strong as that of gene variants on chromosomes 1q31–32 and 10q26 (Allikmets et al., 1997; Baird et al., 2006; Churchill et al., 2006; Zareparsi et al., 2005).”
Background
Cited by
Deng, Y., Qiao, L., Du, M., Qu, C., Wan, L., Li, J., & Huang, L. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.02.009 · Cited by 411
Kaarniranta, K., Sinha, D., Blasiak, J., Kauppinen, A., Veréb, Z., Salminen, A., Boulton, M. E., & Petrovski, G. (2013) · Autophagy · doi:10.4161/auto.24546 · Cited by 326
Rowan, S., Jiang, S., Korem, T., Szymanski, J., Chang, M.-L., Szelog, J., Cassalman, C., Dasuri, K., McGuire, C., Nagai, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702302114 · Cited by 272
Self-citationThe Role of Microbiota in Retinal Disease
Rowan, S., & Taylor, A. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-75402-4_53 · Cited by 89
Self-citationTowards the application of precision medicine in Age-Related Macular Degeneration
Cascella, R., Strafella, C., Caputo, V., Errichiello, V., Zampatti, S., Milano, F., Potenza, S., Mauriello, S., Novelli, G., Ricci, F., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.004 · Cited by 76
“As early treatment options, the oral intake of nutritional supplements has also been shown to prevent the progression of AMD (Weikel et al., 2012; Zampatti et al., 2014; Schmidl et al., 2015).”
Background
Metadata
- Authors
- Weikel, K. A., Chiu, C., & Taylor, A.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 33
- Issue
- 4
- Pages
- 318-375
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2012044361
- Cited by
- 87
- References
- 46
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.